Fed Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg

NCT01183676 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DEPAKOTE® Tablets, 500 MG
DRUG: DIVALPROEX SODIUM DELAYED-RELEASE TABLETS, USP, 500 MG

Sponsor

Mylan Pharmaceuticals Inc